[Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care] - PubMed (original) (raw)
Comparative Study
. 2006 Aug 15;101(8):635-44.
doi: 10.1007/s00063-006-1093-x.
[Article in German]
Günther Karl Stalla, Andreas M Zeiher, Sigmund Silber, Winfried März, Lars Pieper, Jens Klotsche, Heide Glaesmer, Günther Ruf, Harald Jörn Schneider, Hendrik Lehnert, Steffen Böhler, Uwe Koch, Hans-Ulrich Wittchen
Affiliations
- PMID: 16896570
- DOI: 10.1007/s00063-006-1093-x
Comparative Study
[Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care]
[Article in German]
David Pittrow et al. Med Klin (Munich). 2006.
Abstract
Background and purpose: The primary care sector is of key importance for the management of patients with diabetes mellitus. The authors investigated (a) the prevalence of diabetes mellitus type 1 and type 2, (b) the type and frequency of non-drug and drug treatment and its association with the presence of diabetic complications, and (c) the quality of metabolic control by HbA1c.
Methods: Using a nationwide probability sample of 3,188 general practices (response rate [RR] 50.6%), a total of 55,518 (RR 93.5%) patients were assessed in a prospective cross-sectional study by their physicians in September 2003 in a standardized manner using questionnaires, physician interview, and laboratory assessments. In addition to diabetes mellitus, 28 diseases were explicitly screened for, among them typical macrovascular (coronary heart disease, cerebrovascular disease, peripheral arterial disease) and microvascular disease (neuropathy, nephropathy, retinopathy, diabetic foot) complications.
Results: The prevalence of diabetes mellitus was 0.5% (type 1) and 14.7% (type 2), respectively. 49.5% (type 1) and 50.2% (type 2) of patients had micro- or macrovascular complications. 6.8% did not receive any treatment, 13.5% received non-drug treatment, and 75.3% received oral antidiabetic drugs and/or insulin (26.6% a combination of two or more). Compared to diabetics without any complications, treatment intensity was significantly higher in patients with microvascular complications (odds ratio [OR] 3.02), but not in those with macrovascular complications only (OR 0.98). An HbA1c value>or=7.0% was recorded in 39.6% of patients.
Conclusion: Compared to previous studies in this setting, the proportion of diabetics with drug treatment has increased. More patients receive antidiabetic drug combinations. Quality of blood sugar control appears to have improved as well.
Similar articles
- [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
Fabian W, Majkowska L, Stefański A, Moleda P. Fabian W, et al. Przegl Lek. 2005;62(4):201-5. Przegl Lek. 2005. PMID: 16229234 Polish. - [Continuing care of patients with cardiovascular risk in general practice: diabetic patients and their care].
Ilyés I, Jancsó Z, Kovács E, Márton H, Simay A. Ilyés I, et al. Orv Hetil. 2005 Dec 18;146(51):2581-8. Orv Hetil. 2005. PMID: 16468612 Hungarian. - Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program).
Kosiborod M, Gomes MB, Nicolucci A, Pocock S, Rathmann W, Shestakova MV, Watada H, Shimomura I, Chen H, Cid-Ruzafa J, Fenici P, Hammar N, Surmont F, Tang F, Khunti K; DISCOVER investigators. Kosiborod M, et al. Cardiovasc Diabetol. 2018 Nov 28;17(1):150. doi: 10.1186/s12933-018-0787-8. Cardiovasc Diabetol. 2018. PMID: 30486889 Free PMC article. - [Diabetic neuropathy: therapeutic nihilism is no longer acceptable].
Haslbeck M. Haslbeck M. MMW Fortschr Med. 2007 May 21;149 Suppl 2:24, 26-8, 30. MMW Fortschr Med. 2007. PMID: 17724963 Review. German. - [Management of diabetes in patients with hypertension].
González Albarrán O, Ramírez L. González Albarrán O, et al. Hipertens Riesgo Vasc. 2017;34 Suppl 2:30-34. doi: 10.1016/S1889-1837(18)30073-4. Hipertens Riesgo Vasc. 2017. PMID: 29908664 Review. Spanish.
Cited by
- Prevalence, incidence and mortality of diabetes mellitus in adults in Germany - A review in the framework of the Diabetes Surveillance.
Heidemann C, Scheidt-Nave C. Heidemann C, et al. J Health Monit. 2017 Oct 9;2(3):98-121. doi: 10.17886/RKI-GBE-2017-062. eCollection 2017 Oct. J Health Monit. 2017. PMID: 37168946 Free PMC article. - Association Between Socioeconomic Determinants and the Metabolic Syndrome in the German Health Interview and Examination Survey for Adults (DEGS1) - A Mediation Analysis.
Montano D. Montano D. Rev Diabet Stud. 2017 Summer-Fall;14(2-3):279-294. doi: 10.1900/RDS.2017.14.279. Epub 2017 Oct 10. Rev Diabet Stud. 2017. PMID: 29145538 Free PMC article. - A mixed-methods needs assessment of adult diabetes mellitus (type II) and hypertension care in Toledo, Belize.
Dekker AM, Amick AE, Scholcoff C, Doobay-Persaud A. Dekker AM, et al. BMC Health Serv Res. 2017 Feb 28;17(1):171. doi: 10.1186/s12913-017-2075-9. BMC Health Serv Res. 2017. PMID: 28245810 Free PMC article. - Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk.
Laufs U, Karmann B, Pittrow D. Laufs U, et al. Clin Res Cardiol. 2016 Sep;105(9):783-90. doi: 10.1007/s00392-016-0991-z. Epub 2016 Apr 27. Clin Res Cardiol. 2016. PMID: 27120330 Free PMC article. - Lipid management in 13,000 high risk cardiovascular patients treated under daily practice conditions: LIMA Registry.
Schaefer JR, Gitt AK, Sonntag F, Weizel A, Jannowitz C, Karmann B, Pittrow D, Bestehorn K. Schaefer JR, et al. Vasc Health Risk Manag. 2013;9:71-80. doi: 10.2147/VHRM.S37143. Epub 2013 Feb 21. Vasc Health Risk Manag. 2013. PMID: 23459022 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical